Effects of Prebiotics on Intestinal Colonization and Mood in a University Cohort

Beneo-Institute96 enrolled

Overview

There is a growing interest within the scientific community of whether prebiotics can aid in clinical outcomes including mood via modulation of the gut microbiota and its resulting metabolites via the gut-brain axis. This is especially prevalent given that mental health conditions are associated with cost and burden on the health care system. Yet, to date very few studies have investigated the potential effects of prebiotics to influence mood via the modulation of the gut microbiota with previous studies recording mixed results indicating further work in this area would be highly beneficial.

Several reports have suggested that poor mental health among university students is on the increase. Factors driving this; including academic pressure, overdemanding workloads, financial concerns, and peer pressure; can adversely affect academic performance and self-worth. Thus, there is an increasing need to develop new strategies to help tackle these modalities while also reducing the burden on the health system. In recent years there has been increasing interest in the bi-directional relationship that exists between the gut and the brain, a term coined the gut-brain axis, and it is suggested to play a role in influencing mood via chemical messengers. As diet is key manipulator of the gut microbiota one way to influence the composition of the gut is via diet and the use of functional foods including prebiotic oligosaccharides. The idea that functional foods like prebiotics may help to affect mood holds particular appeal due to them being relatively free of side effects, cheap, readily accessible and possessing additional health benefits including improving bowel transit function and improving satiety amongst others. Yet, to date previous research on the potential for prebiotics has produced mixed results due to differences in the populations tested, doses and types of prebiotics used, and means of assessing changes in mood suggesting further work in this area would be highly beneficial. Therefore, this present study aims to address the question "can manipulation of the gut microbiota using prebiotic oligosaccharides alone or in combination influence mental state in a taught university student population?".

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Conditions

Mood

Interventions

PlaceboDIETARY_SUPPLEMENT

maltodextrin taken daily for 4 weeks with water

Prebiotic supplementDIETARY_SUPPLEMENT

Prebiotic supplement taken daily for 4 weeks with water

Prebiotic combinationDIETARY_SUPPLEMENT

prebiotic oligosaccharides mixture taken daily for 4 weeks with water

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Volunteer is healthy at the time of pre-examination * Possess mild/moderately elevated levels of stress * Volunteer is aged ≥ 18 to ≤ 45 years at the time of pre-examination * Volunteer's BMI is ≥ 18.5 and ≤ 29.9 * Volunteer has a stool frequency of at least 3 bowel movements per week * Volunteer is able and willing to comply with the study instructions * Volunteer is suitable for participation in the study according to the investigator/study personnel * Written informed consent is given by volunteer Exclusion Criteria: * No command of any local language * Previously or currently diagnosed neurological or psychiatric disorders * Previous history of renal, hepatic, cardiovascular disease or clinically significant diabetes * Gastrointestinal disorders including IBS, IBD or other conditions that might affect the gut environment * Food allergies or intolerances * Using drugs (e.g. antibiotics, aspirin, proton pump inhibitors) influencing gastrointestinal function (8 weeks before intervention) * Use of laxatives and labelled pre-and probiotics in the previous 4 weeks before the beginning of intervention * Volunteers currently involved or will be involved in another clinical or food study * History of drug (recreational) or alcohol abuse. * Use of anti-depressants medication including selective serotonin receptor inhibitors or Amitriptyline for 3 months prior to commencing the trial * Received bowel preparation for investigative procedures in the 4 weeks prior to the study * Undergone surgical resection of any part of the bowel. * pregnant or lactating

Locations (1)

University of Reading

Reading, United Kingdom

Outcomes

Primary Outcomes

Bifidobacterium spp in stool samples

Bifidobacterium spp. will be assessed in stool samples by molecular biological methods

Time frame: 4 weeks

Anxiety with State-Trait Anxiety Inventory questionnaire

Anxiety will be assessed with anxiety questionnaire at baseline and at the end of intervention

Time frame: 4 weeks

Depression with Beck's Depression Inventory questionnaire

Depression will be assessed with depression questionnaire at baseline and at the end of intervention

Time frame: 4 weeks

Salivary IgA

Salivary IgA will be assessed by ELISA at baseline and at the end of intervention

Time frame: 4 weeks

Secondary Outcomes

Total bacteria in stool samples

Total bacteria will be assessed in stool samples by molecular biological methods

Time frame: 4 weeks

Changes in microbiota composition

Microbiota composition at baseline and end will be assessed by 16S rRNA gene sequencing

Time frame: 4 weeks

Stool frequency

Stool frequency will be assessed as effective number of bowel movements in a daily diary during baseline and intervention periods

Time frame: 5 weeks

Stool consistency according to Bristol Stool Form Scale

Stool consistency will be assessed in a daily diary during baseline and intervention periods

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.